Last reviewed · How we verify
Alpha-lipoic acid — Competitive Intelligence Brief
marketed
Antioxidant / Mitochondrial cofactor
Metabolic / Endocrinology
Small molecule
Live · refreshed every 30 min
Target snapshot
Alpha-lipoic acid (Alpha-lipoic acid) — Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara. Alpha-lipoic acid is an antioxidant that regenerates other antioxidants and modulates cellular energy metabolism by acting as a cofactor for mitochondrial enzyme complexes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Alpha-lipoic acid TARGET | Alpha-lipoic acid | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | marketed | Antioxidant / Mitochondrial cofactor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Antioxidant / Mitochondrial cofactor class)
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Alpha-lipoic acid CI watch — RSS
- Alpha-lipoic acid CI watch — Atom
- Alpha-lipoic acid CI watch — JSON
- Alpha-lipoic acid alone — RSS
- Whole Antioxidant / Mitochondrial cofactor class — RSS
Cite this brief
Drug Landscape (2026). Alpha-lipoic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/alpha-lipoic-acid. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab